167 related articles for article (PubMed ID: 30954508)
1. Isolation and functional characterization of a novel endogenous inverse agonist of estrogen related receptors (ERRs) from human pregnancy urine.
Ghanbari F; Hebert-Losier A; Barry J; Poirier D; Giguere V; Mader S; Philip A
J Steroid Biochem Mol Biol; 2019 Jul; 191():105352. PubMed ID: 30954508
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-related receptors alpha, beta and gamma expression and function is associated with transcriptional repressor EZH2 in breast carcinoma.
Kumari K; Adhya AK; Rath AK; Reddy PB; Mishra SK
BMC Cancer; 2018 Jun; 18(1):690. PubMed ID: 29940916
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel inverse agonists of estrogen-related receptors ERRγ and ERRβ.
Yu DD; Huss JM; Li H; Forman BM
Bioorg Med Chem; 2017 Mar; 25(5):1585-1599. PubMed ID: 28189393
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a selective inverse agonist for estrogen related receptor α as a potential agent for breast cancer.
Zhang L; Liu P; Chen H; Li Q; Chen L; Qi H; Shi X; Du Y
Eur J Pharmacol; 2016 Oct; 789():439-448. PubMed ID: 27498368
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
Ariazi EA; Clark GM; Mertz JE
Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
[TBL] [Abstract][Full Text] [Related]
6. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors.
Lu D; Kiriyama Y; Lee KY; Giguère V
Cancer Res; 2001 Sep; 61(18):6755-61. PubMed ID: 11559547
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related receptors as emerging targets in cancer and metabolic disorders.
Ariazi EA; Jordan VC
Curr Top Med Chem; 2006; 6(3):203-15. PubMed ID: 16515477
[TBL] [Abstract][Full Text] [Related]
9. Estrogen-related receptor-alpha antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts.
Chisamore MJ; Wilkinson HA; Flores O; Chen JD
Mol Cancer Ther; 2009 Mar; 8(3):672-81. PubMed ID: 19276159
[TBL] [Abstract][Full Text] [Related]
10. The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
Du Y; Song L; Zhang L; Ling H; Zhang Y; Chen H; Qi H; Shi X; Li Q
Eur J Med Chem; 2017 Aug; 136():457-467. PubMed ID: 28525844
[TBL] [Abstract][Full Text] [Related]
11. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues.
Cheung CP; Yu S; Wong KB; Chan LW; Lai FM; Wang X; Suetsugi M; Chen S; Chan FL
J Clin Endocrinol Metab; 2005 Mar; 90(3):1830-44. PubMed ID: 15598686
[TBL] [Abstract][Full Text] [Related]
12. Recent advance in the design of small molecular modulators of estrogen-related receptors.
Lu X; Peng L; Lv M; ding K
Curr Pharm Des; 2012; 18(23):3421-31. PubMed ID: 22632982
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.
Tanida T; Matsuda KI; Yamada S; Hashimoto T; Kawata M
J Biol Chem; 2015 May; 290(19):12332-45. PubMed ID: 25805499
[TBL] [Abstract][Full Text] [Related]
14. Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer.
Ijichi N; Shigekawa T; Ikeda K; Horie-Inoue K; Fujimura T; Tsuda H; Osaki A; Saeki T; Inoue S
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):1-7. PubMed ID: 20883782
[TBL] [Abstract][Full Text] [Related]
15. Dimerization modulates the activity of the orphan nuclear receptor ERRgamma.
Huppunen J; Aarnisalo P
Biochem Biophys Res Commun; 2004 Feb; 314(4):964-70. PubMed ID: 14751226
[TBL] [Abstract][Full Text] [Related]
16. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
17. Subcellular dynamics of estrogen-related receptors involved in transrepression through interactions with scaffold attachment factor B1.
Tanida T; Matsuda KI; Uemura T; Yamaguchi T; Hashimoto T; Kawata M; Tanaka M
Histochem Cell Biol; 2021 Sep; 156(3):239-251. PubMed ID: 34129097
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors.
Zhang Z; Chen K; Shih JC; Teng CT
Mol Endocrinol; 2006 Jul; 20(7):1547-61. PubMed ID: 16484337
[TBL] [Abstract][Full Text] [Related]
19. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth.
Tiraby C; Hazen BC; Gantner ML; Kralli A
Cancer Res; 2011 Apr; 71(7):2518-28. PubMed ID: 21339306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
